While the two luminal subtypes are characterized by high hormone receptor expression and generally have a better prognosis, the basal-like breast cancers are a heterogeneous group of hormone receptor- and HER2-negative breast cancers that are highly proliferative and often metastasize early. The gene discussed is ERBB2; the disease is breast carcinoma.